2016 Europe Nucleic Acid Testing/NAT Market Report - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/dvnh4k/2016_europe) has announced the addition of the "2016 Europe Nucleic Acid Testing/NAT Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities" report to their offering.

This new 1,273-page comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.

Table of Contents

I. Introduction

II. Worldwide Technology and Market Overview

A. DNA Sequencing

B. DNA and RNA Probes Technology

C. Detection Technologies

D. Instrumentation Review

E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip

F. Pharmacogenomics

G. Major Applications

III. France

IV. Germany

V. Italy

VI. Spain

VII. U.K.

VIII. Major Product Development Opportunities

IX. Design Criteria for Decentralized Testing Products

X. Alternative Market Penetration Strategies

XI. Potential Market Entry Barriers and Risks

XII. Competitive Assessments

XIII. Appendix

Companies Mentioned

- Abbott

- Affymetrix

- Agilent Technologies

- Applied Gene Technologies

- Arca Biopharma

- Beckman Coulter/Danaher

- Becton Dickinson

- Biokit

- bioMerieux

- Bio-Rad

- Biotest

- Cepheid

- CellMark Forensics/LabCorp

- Decode Genetics

- Diade

For more information visit http://www.researchandmarkets.com/research/dvnh4k/2016_europe

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics, Molecular Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics, Molecular Diagnostics